Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper (Q38206795)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 April 2014

Language	Label	Description	Also known as
English	Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper	scientific article published on 25 April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

31 August 2017

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper (English)

1 reference

Europe PubMed Central

31 August 2017

rhinoconjunctivitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Giorgio Walter Canonica

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Nikolaos G Papadopoulos

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Pablo Rodríguez del Río

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Stephen R Durham

7

object named as

S R Durham

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

5

object named as

J Bousquet

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1

object named as

O Pfaar

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

P Demoly

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

R Gerth van Wijk

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

L Jacobsen

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

H J Malling

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

R Mösges

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

S Rak

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

E Valovirta

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

U Wahn

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

M A Calderon

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

European Academy of Allergy and Clinical Immunology

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

25 April 2014

1 reference

Europe PubMed Central

31 August 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

69

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

854-867

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24761804%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials?

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

An introduction to patient decision aids

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Quality of life during pollen season in patients with seasonal allergic rhinitis with or without asthma.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Measuring quality of life in children with rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

RhinAsthma patient perspective: a short daily asthma and rhinitis QoL assessment.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Interpretation of rhinoconjunctivitis quality of life questionnaire data

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The visual analogue scale: its use in pain measurement.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

'Well days' after sublingual immunotherapy with a high-dose 6-grass pollen preparation.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Validation of the first treatment-specific questionnaire for the assessment of patient satisfaction with allergen-specific immunotherapy in allergic patients: the ESPIA questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Control of allergic rhinitis and asthma test--a formal approach to the development of a measuring tool.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The precision of the conjunctival provocation test

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

The chronic care model and diabetes management in US primary care settings: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Unmet needs in severe chronic upper airway disease (SCUAD).

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Prospective validation of the "rhino conjunctivitis allergy-control-SCORE©" (RC-ACS©).

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Assessment of disease control in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA2LEN taskforce position paper

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes

1 reference

https://api.crossref.org/works/10.1111%2FALL.12383

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38206795&oldid=2160891795"